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Abstract We have identified novel G protein-coupled receptors
(GPCRs) with no introns in the coding region from the human
genome sequence: 322 olfactory receptors; 22 taste receptors;
128 registered GPCRs for endogenous ligands; 50 novel GPCR
candidates homologous to registered GPCRs for endogenous
ligands; and 59 novel GPCR candidates not homologous to
registered GPCRs. The total number of GPCRs with and
without introns in the human genome was estimated to be
approximately 950, of which 500 are odorant or taste receptors
and 450 are receptors for endogenous ligands. . 2002 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
G protein-coupled receptors (GPCRs) are integral mem-
brane proteins in the cell surface, and interact with and are
activated by exogenous ligands, such as odorants and taste
substances, or by endogenous ligands such as neurotransmit-
ters and hormones in the extracellular space. Activated
GPCRs interact with and activate the heterotrimeric form of
G proteins in the intracellular space. GPCRs are also known
to be targets of 30^60% of the present drugs. Identi¢cation of
unknown GPCRs in the human genome and endogenous li-
gands for them should give a great impetus not only to our
understanding of human physiology but also to the develop-
ment of novel drugs.
GPCRs comprise one of the largest protein superfamilies. It
is estimated that there are 1050 and 160 GPCR genes in the
genomes of Caenorhabditis elegans [1] and Drosophila mela-
nogaster [2], corresponding to 5.5% and 1% of their total
genes, respectively. Recently, Venter et al. [3] reported the
presence of 616 GPCR genes that belonged to the rhodopsin
class, the secretin class and the metabotropic glutamate class
in the human genome. It is estimated that in mice there are
500^1000 odorant receptors [4] and 40^50 taste receptors [5].
The lists on web sites enumerate over 200 non-odorant and
non-taste human GPCRs (http://www.expasy.ch/cgi-bin/
lists?7tmrlist.txt, http://www.gpcr.org/7tm/seq/dna.html) and
over 300 odorant human GPCRs (http://bioinfo.weizmann.
ac.il/HORDE/). Thus, many unregistered GPCR genes appear
to exist in the human genome. There may be novel GPCRs
that are not homologous to already registered GPCRs and
that are di⁄cult to ¢nd by using a simple homology search
method. Although increasing attention is being paid to ¢nd
novel genes in several genome databases, gene annotation is
not su⁄ciently reliable yet. In fact, di¡erent methods of iden-
tifying genes from genome data do not give good agreement
for predicting novel genes [6]. To classify novel GPCR genes
in the human genome, we attempted to develop a new strategy
for screening GPCR genes.
To identify GPCR genes, we took advantage of the fact
that many mammalian GPCR genes do not have introns in
their coding region [7] and attempted to screen GPCR genes
with no introns in the coding regions. Thus, we could avoid
the very di⁄cult and risky task of predicting the exon^intron
boundary in the genome sequences. We collected intronless
open reading frames (ORFs), which were long enough to cov-
er GPCRs from the human genome. Then we took advantage
of the GPCRs’ common characteristic that they have seven
transmembrane segments, and adopted the program SOSUI
which was developed to identify transmembrane segments in
protein sequences and to discriminate membrane proteins.
The reliability of SOSUI was 99% for the discrimination be-
tween soluble and membrane proteins and 96% for the pre-
diction of transmembrane helices [8]. SOSUI has recently been
used to analyze all proteins in whole genomes of 15 single-cell
organisms [9].
Here, we report on the identi¢cation of novel GPCR genes
and on our estimation of the total number of GPCRs in the
human genome.
2. Materials and methods
We downloaded the human genome database dated August 8, 2000
from ftp://ncbi.nlm.nih.gov/genbank/genomes/H-sapiens/. The ‘nr’
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protein database dated August 20, 2000 was obtained from ftp://
ncbi.nlm.nih.gov/blast/db/. BLAST for the linux operating system
was downloaded from ftp://ncbi.nlm.nih.gov/blast/executables/ and
used for homology search. Registered GPCR sequences were obtained
from web sites: 207 non-odorant and non-taste receptors from http://
www.gpcr.org/7tm/seq/dna.html, and 43 odorant GPCRs from http://
ycmi.med.yale.edu/senselab/ORDB. Selected ORFs were analyzed for
homology using BLAST with the ‘nr’ protein database. Human tissue
RNA fractions for RT-PCR were obtained from BioChain. RT-PCR
was performed with Superscript II reverse transcriptase (Invitrogen)
and KOD plus (Toyobo) polymerase.
3. Results and discussion
We translated the human genome data and extracted
335 570 ORFs which had 200^1500 amino acid residues.
Over 97% of the 250 GPCRs registered on the web sites
had amino acid residues in this range. We eliminated the
ORFs in which any single amino acid residue comprised
more than 20% of the whole sequence because most likely
they are repeated sequences rather than coding regions.
More than 99% of the registered GPCRs passed this proce-
dure and 27 512 ORFs were removed.
The remaining ORFs were analyzed by SOSUI. Some of the
registered GPCRs were recognized as having six or eight
transmembrane segments by SOSUI when one of the trans-
membrane segments was not very hydrophobic or when a
signal peptide was interpreted as a transmembrane segment.
We selected as GPCR candidates the 7780 ORFs which were
judged to have six to eight transmembrane segments. When
multiple ORFs with di¡erent initiation codons were £anked
by the same stop codon only the longest ORF was adopted.
We also removed redundant ORFs when they were over 95%
homologous to each other, by BLAST search. After selecting,
we obtained 1714 non-redundant ORFs. These ORFs were
analyzed for their homology with protein sequences in data-
bases. One hundred and eighty were the same as GPCRs al-
ready registered and 342 were 20% or more homologous to
GPCRs already registered (Table 1).
There were 322 putative odorant receptors, 41 of which had
been registered as such, and 281 were 40^85% homologous to
registered odorant receptors. Recently, Glusman et al. [10]
also reported the presence of 322 odorant receptor genes in
the human genome. Putative taste receptors were also de-
tected, including 11 registered ones and 11 novel ones with
homology of 30^70% to registered bitter receptors of mouse
or rat. These bitter receptor candidates were encoded by genes
with no intron in the coding region and had a short N-termi-
nal extracellular segment in accord with bitter receptors
[5,11,12], whereas sweet receptors are known to have introns
and a long extracellular segment [13^16].
We also found non-odorant and non-taste GPCRs: 128 of
the GPCRs for endogenous ligands had already been regis-
tered on the ‘nr’ database as of August 20, 2000 and 50 of the
GPCR candidates had not been registered on the database.
The homology search indicated that out of the 50 GPCR
candidates, eight were homologous to amine receptors, four
to peptide receptors, six to nucleotide receptors, four to lipid
receptors, six to putative pheromone receptors, nine to vari-
ous kinds of GPCRs, and 13 to orphan receptors (Table 2).
After completion of our computational screening, it turned
out that 50 GPCR candidates contained an ADP receptor
(hGPCR17) [17,18] and pheromone receptor candidate,
V1RL1 (hGPCR25) [19]. Eventually, 37 of the 50 GPCR can-
didates were registered as new GPCRs on a public database
between August 2000 and April 2002. These results indicate
the potential of our strategy to screen novel GPCRs. Rhodop-
sin and other pigment opsins, sweet receptors, and opioid
receptors were not detected, because they have introns in their
coding regions. On the other hand, we could identify several
GPCR genes with introns outside their seven transmembrane
segment region, such as glutamate receptors 1 and 2.
The pheromone receptor homologues, vomeronasal recep-
tor-like 1^6 (VNRL1^6), were divided to two categories ac-
cording to their homology. VNRL1^5 were similar to the
pheromone receptors of rodents, with a short extracellular
sequence at the N-terminus. Only VNRL6 was homologous
to V2R2 of rodents, with a long N-terminal extracellular do-
main. We could not, however, detect the long N-terminal
domain in VNRL6. It is possible that the N-terminal domain
is encoded in exons other than those encoding the seven trans-
membrane regions. RT-PCR revealed that, except VNRL2,
these pheromone receptor-likes were expressed in the human
olfactory nerve of a 36 year old man (Fig. 1). VNRL2 might
be expressed at a speci¢c age or only in females. In the ge-
nome, VNRL2 and 3 were located very close to each other,
Fig. 1. RT-PCR was performed on mRNA from olfactory nerve tis-
sue of a 36 year old man for putative pheromone receptors. VNRL1
is the same gene as V1RL1 reported previously [19]. The PCR prod-
ucts, ampli¢ed from the genome and the olfactory nerve mRNA,
have the same size, indicating that these mRNA sequences were not
divided by an intron on the genome.
Table 1
Number of identi¢ed GPCRs and estimation of total number of GPCRs in the human genome
Number of identi¢ed receptorsa
(already registered receptors)
Estimated number of total
receptorsb
Odorant receptors 322 (41) 481
Taste receptors 22 (11) 28
Receptors for endogenous ligands 178 (128) 330
ORFs without homology to registered GPCRsc 59 (0) 109
Total 581 (180) 948
aNumbers in parentheses are those for already registered GPCRs in the ‘nr’ protein database.
bThe total numbers of GPCRs in each category were estimated using performance of the present strategy, which is shown in Table 3.
cSee text for criteria to discriminate GPCR candidates from non-candidates.
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Table 2
Summary of 50 novel GPCR candidates
Tentative
identi¢cation number
Homologous receptorsa Homol-
ogy (%)
Identical
residues/
homologous
regionb
Tissue
speci¢cityc
Accession
numberd
Corresponding
mRNAe
Amine receptors
hGPCR1 serotonin receptor 4 21 64/295 brain AB083583 NM014373
hGPCR2 dopamine receptor 1 27 95/350 ubiquitous AB083584 XM066873
hGPCR3 histamine H2 27 87/312 brain AB083585 NM031936
hGPCR4 melatonin receptor type 1A 26 98/364 ubiquitous AB083586 NM020370
hGPCR5 L3-adrenergic receptor 32 39/120 AB083587
hGPCR6 serotonin receptor 1A 22 101/455 brain AB083588 NM054021
hGPCR7 serotonin receptor 1D 26 72/272 AB083589
hGPCR8 serotonin receptor 6 28 99/344 brain AB083590
Peptide receptors
hGPCR9 allatostatin receptor 27 43/154 small intestine AB083591 XM069498
hGPCR10 galanin receptor type 3 23 79/330 AB083592 XM068829
hGPCR11 somatostatin- and angiotensin-like
SALPR
43 141/322 small intestine AB083593 XM060898
hGPCR12 thyrotropin-releasing hormone receptor 23 76/326 AB083594 XM064062
Nucleotide receptors
hGPCR13 GPR34 23 77/323 ubiquitous AB083595 XM080817
hGPCR14 KIAA0001 47 149/314 ubiquitous AB083596 NM022788
hGPCR15 KIAA0001 47 140/295 ubiquitous AB083597 NM023914
hGPCR16 putative purinergic receptor P2Y1 36 109/299 colon AB083598 XM062888
hGPCR17 putative purinergic receptor P2Y10 50 148/292 ubiquitous AB083599 NM032553
hGPCR18 putative purinergic receptor P2Y5 39 113/284 ubiquitous AB083600 NM020400
Lipid receptors
hGPCR19 EDG-6 28 76/268 ubiquitous AB083601
hGPCR20 EDG-8 86 343/397 ubiquitous AB083602 XM085864
hGPCR21 leukotriene D4 receptor 38 114/298 ubiquitous AB083603 NM020377
hGPCR22 leukotriene B4 receptor 33 92/276 ubiquitous AB083604 NM019839
Pheromone receptors
hGPCR23 (VNRL4) pheromone receptor 1 43 90/206 olfactory nerve AB083605
hGPCR24 (VNRL1) pheromone receptor M21 28 86/300 olfactory nerve AB083606 NM020633
hGPCR25 (VNRL3) pheromone receptor VN3 30 84/277 olfactory nerve AB083607 XM064908
hGPCR26 (VNRL5) pheromone receptor VN6 31 99/310 olfactory nerve AB083608
hGPCR27 (VNRL2) pheromone receptor VN6 33 79/236 AB083609 XM064909
hGPCR28 (VNRL6) pheromone receptor V2R2 76 250/327 olfactory nerve AB083610 XM067401
Others
hGPCR29 Frizzled-1 32 27/82 AB083611
hGPCR30 Frizzled-3 70 197/278 AB083612
hGPCR31 Frizzled-4 53 235/438 AB083613 NM012193
hGPCR32 Frizzled-10 23 23/96 AB083614
hGPCR33 calcium ion sensing receptor 45 132/288 AB083615 XM069224
hGPCR34 G protein-coupled receptor LGR5 44 120/269 ubiquitous AB083616 XM086283
hGPCR35 KIAA0758 44 177/398 AB083617 XM069343
hGPCR36 KIAA0758 38 187/480 AB083618
hGPCR37 KIAA0758 25 114/444 ubiquitous AB083619 XM092364
Orphan receptors
hGPCR38 FMLP-related receptor I 27 90/324 AB083620 XM061833
hGPCR39 GPR32 84 199/236 AB083621 XM064958
hGPCR40 GPR34 23 77/323 ubiquitous AB083622
hGPCR41 hypothetical protein similar to GPCR
(C. elegans)
24 55/226 AB083623
hGPCR42 hypothetical protein similar to GPCR
(C. elegans)
23 69/288 ubiquitous AB083624 NM017986
hGPCR43 hypothetical protein similar to GPCR
(D. melanogaster)
23 59/253 ubiquitous AB083625
hGPCR44 Mas proto-oncogene 37 111/294 small intestine,
colon
AB083626 NM054030
hGPCR45 Mas proto-oncogene 34 113/327 AB083627 XM089955
hGPCR46 Mas proto-oncogene 38 108/283 AB083628 XM089843
hGPCR47 retinoic acid-induced putative GPCR 47 138/290 AB083629 NM018654
hGPCR48 probable GPCR HM74 41 122/294 AB083630 XM092406
hGPCR49 probable GPCR HM74 52 178/341 AB083631 NM032554
hGPCR50 probable GPCR HM74 92 335/362 AB083632 XM090326
aThe homology to registered GPCRs in the ‘nr’ protein database dated August 20, 2000 was estimated by BLAST.
bNumber of identical amino acid residues/length of amino acid residues for homologous region.
cExpression pro¢les were determined by RT-PCR. Only high expression tissues were noted.
dNucleotide sequence data are available in the DDBJ databases under these accession numbers.
eAccession number for public database is shown in the case that an ORF was registered after August 2000.
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within 60 000 bases, on chromosome 19. In contrast, VNRL1
was isolated from VNRL2 and 3 on chromosome 19. VNRL4
and 5 were within 20 000 bases of each other on chromosome 1.
Similar analyses were also performed for other novel GPCR
gene candidates. RT-PCR revealed at least 27 GPCR candi-
dates expressed in some tissues (Table 2). We identi¢ed several
gene clusters for odorant and taste receptors as described
recently [10,12] (Fig. 2a). Moreover, we found a tandem struc-
ture of orphan receptor genes. Four homologues of purinergic
receptors were within 60 000 bases of each other on chromo-
some 3 (Fig. 2b) and two homologues of Mas proto-onco-
genes were within 350 000 bases of each other on chromosome
11. Registered ‘retinoic acid-induced putative GPCR’ and its
novel homologue, hGPCR48, were within 40 000 bases of each
other on chromosome 12.
Many ORFs had six to eight transmembrane segments ac-
cording to SOSUI but were not signi¢cantly homologous to
the registered GPCRs. We have introduced two criteria to
discriminate between the GPCR candidates and the non-can-
didates. Firstly, we eliminated ORFs homologous to mem-
brane-bound proteins including enzymes, ion channels, other
kinds of receptors, transporters and virus proteins. Secondly,
we chose ORFs with intra- and extracellular loops with
lengths comparable to those of registered GPCRs. In general,
extracellular loops and the ¢rst and second intracellular loops
of GPCRs consist of 10^30 amino acid residues. The third
intercellular loops of some GPCRs consist of more than 100
residues. Considering these facts, we eliminated ORFs with a
long loop of more than 70 residues except for the third inter-
cellular loop or a short loop of fewer than ¢ve residues. ORFs
with only six transmembrane segments and fewer than 30
residues at both the N-terminus and the C-terminus were
also eliminated. Finally, we chose 59 ORFs as GPCR candi-
dates. They may represent a new class of GPCRs, although
this remains to be con¢rmed. It should be noted that they
could not be identi¢ed by homology search alone.
We have screened GPCRs with no intron in the coding
region from the human genome. In order to estimate the total
number of GPCRs, we ¢rst checked the proportions of intron-
less GPCRs for 152 of the registered GPCRs of which both
cDNA and genomic clones had been sequenced (Table 3a).
We did not ¢nd introns for human odorant receptor genes in
the public database. In taste receptors, 11 bitter receptors
were intronless [5,11] and three sweet receptors contained in-
trons [13^15]. There were 63 intronless ORFs out of 95 known
GPCR genes that had endogenous ligands. We also tested if
the registered GPCRs could be predicted correctly as having
six to eight transmembrane segments by SOSUI analysis (Ta-
ble 3b). Correct prediction was obtained for 77% of the 43
odorant receptors, 100% of the 11 taste receptors and 95% of
the 207 receptors for endogenous ligands. It remains unknown
why the performance for odorant receptors was much less
than for the other receptors. In addition, we checked which
proportion of registered GPCR genes could be found in the
database that we used in the present screening (Table 3c). We
found 79% of the 43 odorant receptors, 100% of the 11 taste
receptors and 90% of the 207 receptors for endogenous li-
gands.
The e⁄ciency of the present screening method was indepen-
dently checked by subjecting registered GPCR genes to the
present system. We obtained recoveries of 67% of the odorant
receptors, 79% of the taste receptors and 54% of the receptors
for endogenous ligands. The recovery value of 54% for recep-
tors for endogenous ligands was essentially the same as the
products (56%) of three factors ^ the proportion of intronless
(66%) GPCRs, the performance of SOSUI (95%), and the
completeness of the genome (90%). Similar correspondence
was also observed for odorant receptors (67% vs. 61%) and
taste receptors (79% vs. 79%) (Table 3). These results indicate
that the e⁄ciency of the present screening strategy depends
solely on the above three factors.
On the assumption that the e⁄ciency to screen novel
GPCRs is the same between registered and non-registered
GPCRs, we estimated the total number of GPCRs in the
human genome to be 839 (Table 1). This consists of 481 odor-
ant receptors, 28 taste receptors, and 330 receptors for endog-
enous ligands. In addition, approximately 100 ORFs might
represent a new class of GPCRs as they were not homologous
to registered GPCRs.
Finally, we summarize some shortcomings in the present
strategy. Firstly, some of the novel GPCR gene candidates
could be pseudo-genes. We could exclude this possibility for
Fig. 2. Gene clusters of putative GPCRs were found on the human
genome. a: Taste receptors formed a cluster on chromosome 12.
The dotted lines correspond to registered taste receptors [11], and
the solid lines to novel taste receptor candidates. b: Nucleotide re-
ceptors and their homologues formed a tandem structure on chro-
mosome 3. KIAA0001 and P2RY12 were receptors for UDP-glucose
[20] and ADP [17,18], respectively. The dotted lines correspond to
registered receptors and the solid lines to novel receptors in this
study.
Table 3
Performance of the present screening applied for already registered GPCRs
Odorant receptors Taste receptorsa Receptors for endogenous ligand
(a) Proportion of intronless GPCR genes 100% (43/43) 79% (11/14) 66% (63/95)
(b) Performance of SOSUI 77% (33/43) 100% (11/11) 95% (197/207)
(c) Completeness of the genome data 79% (34/43) 100% (11/11) 90% (186/207)
(a)U(b)U(c) 61% 79% 56%
Performance of the present screening 67% (29/43) 79% (11/14) 54% (111/207)
aFor taste receptors, 11 bitter receptors and three sweet receptors were employed. Umami receptor, truncated mGluR4 [18], was categorized in
‘receptors for endogenous ligand’.
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several GPCR candidates, by RT-PCR, but not for all. Sec-
ondly, there is a possibility that the ORFs identi¢ed here may
contain an intron^exon boundary and therefore they may not
correspond to proteins with seven successive transmembrane
segments or may be expressed with the extra N- or C-terminal
tails. Cloning of corresponding cDNA should solve these
problems. The ¢nal goal of the present project should be
attained when endogenous ligands for these GPCR candidates
are identi¢ed.
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